Clinical evaluation of the efficacy and liquid molecular analysis of abemaciclib rechallenge upon progression to abemaciclib combination therapies for ER-positive HER2-negative metastatic breast cancer patients

被引：0
|
作者：
Nishimura, Meiko
Kogawa, Takahiro
Akaishi, Yuko
Ogata, Misato
Masuda, Jun
Terada, Mitsuo
Sakai, Hitomi
Nozawa, Kazuki
Kurozumi, Sasagu
Yokoe, Takamichi
Ozaki, Yukinori Ozaki
Yazaki, Shu
Onishi, Mai
Iwasa, Tsutomu
Onoe, Takuma
Okumura, Yuta
Nakayama, Sayaka
Hagio, Kanako
Takahashi, Yuko
Tanino, Hirokazu
Tsurutani, Junji
Matsumoto, Koji
Shimokawa, Mototsugu
Takano, Toshimi
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-OT2-19-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT2-19-02
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Phase II study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea in patients with ER-positive and HER2-negative advanced breast cancer (MERMAID) WJOG11318B
    Masuda, Hiroko
    Iwasa, Tsutomu
    Mukohara, Toru
    Tokunaga, Shinya
    Matsumoto, Koji
    Niikura, Naoki
    Sagara, Yasuaki
    Miyoshi, Yasuo
    Shimomura, Akihiko
    Takahashi, Masato
    Nagashima, Takeshi
    Doi, Mihoko
    Futamura, Manabu
    Yoshimura, Kenichi
    Takano, Toshimi
    Tsurutani, Junji
    CANCER RESEARCH, 2020, 80 (04)
  • [32] Genomic risk analyses in patients with clinical low risk ER-positive HER2-negative early breast cancer developing an early metastatic event
    Van Cauwenberge, Josephine
    Izci, Hava
    Wildiers, Hans
    Han, Sileny
    Desmedt, Christine
    Floris, Giuseppe
    Vander Borght, Sara
    Smeets, Ann
    Nevelsteen, Ines
    Vanden Bempt, Isabelle
    Neven, Patrick
    CANCER RESEARCH, 2024, 84 (09)
  • [33] Incidence and management of diarrhoea associated with abemaciclib and endocrine therapy for hormone-receptor positive, HER2-negative metastatic breast cancer: the UK patients’ experiences
    Helena Harder
    Rachel Starkings
    Lesley Fallowfield
    Shirley May
    Valerie Shilling
    Supportive Care in Cancer, 2025, 33 (5)
  • [34] 20-year tamoxifen benefit in ER-positive/HER2-negative breast cancer patients in randomized clinical trials
    Dar, H. A.
    Johansson, A.
    Nordenskjold, A.
    Yau, C.
    Benz, C.
    Essermann, L.
    Rodriguez-Wallberg, K. A.
    Nordenskjold, B. A.
    Perez-Tenorio, G.
    Stal, O.
    Fornander, T.
    Lindstrom, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S153 - S154
  • [35] Estimating the magnitude of clinical benefit from (neo)adjuvant chemotherapy in patients with ER-positive/HER2-negative breast cancer
    McCartney, Amelia
    Benelli, Matteo
    Di Leo, Angelo
    BREAST, 2019, 48 : S81 - S84
  • [36] Mechanisms of primary AI resistance in ER-positive HER2-negative breast cancer.
    Miura, Daishu
    Iwatani, Tsuguo
    Kawabata, Hidetaka
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer
    Ueno, Takayuki
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [38] Reply to: Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer
    Goldhirsch, A.
    Coates, A. S.
    ANNALS OF ONCOLOGY, 2014, 25 (03) : 755 - 755
  • [39] Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
    Hohmann, Lennart
    Sigurjonsdottir, Kristin
    Campos, Ana Bosch
    Nacer, Deborah F.
    Veerla, Srinivas
    Rosengren, Frida
    Reddy, Poojaswini Thimmaraya
    Hakkinen, Jari
    Nordborg, Nicklas
    Vallon-Christersson, Johan
    Memari, Yasin
    Black, Daniella
    Bowden, Ramsay
    Davies, Helen R.
    Borg, Ake
    Nik-Zainal, Serena
    Staaf, Johan
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [40] Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer
    Constantinidou, Anastasia
    Marcou, Yiola
    Toss, Michael S.
    Simmons, Timothy
    Bernhisel, Ryan
    Hughes, Elisha
    Probst, Braden
    Meek, Stephanie
    Kakouri, Eleni
    Georgiou, Georgios
    Zouvani, Ioanna
    Savvidou, Gabriella
    Kuhl, Vanessa
    Doedt, Jennifer
    Wagner, Susanne
    Gutin, Alexander
    Slavin, Thomas P.
    Lanchbury, Jerry S.
    Kronenwett, Ralf
    Ellas, Ian O.
    Rakha, Emad A.
    CLINICAL CANCER RESEARCH, 2022, 28 (20) : 4435 - 4443
12345